The Conformational Variability of FimH: Which Conformation Represents the Therapeutic Target?
Authors:
- 15 March 2016
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 17 (11) , 1012-1020
Abstract
FimH is a bacterial lectin found at the tips of type 1 pili of uropathogenic Escherichia coli (UPEC). It mediates shear‐enhanced adhesion to mannosylated surfaces. Binding of UPEC to urothelial cells initiates the infection cycle leading to urinary tract infections (UTIs). Antiadhesive glycomimetics based on α‐d‐mannopyranose offer an attractive alternative to the conventional antibiotic treatment because they do not induce a selection pressure and are therefore expected to have a reduced resistance potential. Genetic variation of the fimH gene in clinically isolated UPEC has been associated with distinct mannose binding phenotypes. For this reason, we investigated the mannose binding characteristics of four FimH variants with mannose‐based ligands under static and hydrodynamic conditions. The selected FimH variants showed individually different binding behavior under both sets of conditions as a result of the conformational variability of FimH. Clinically relevant FimH variants typically exist in a dynamic conformational equilibrium. Additionally, we evaluated inhibitory potencies of four FimH antagonists representing different structural classes. Inhibitory potencies of three of the tested antagonists were dependent on the binding phenotype and hence on the conformational equilibrium of the FimH variant. However, the squarate derivative was the notable exception and inhibited FimH variants irrespective of their binding phenotype. Information on antagonist affinities towards various FimH variants has remained largely unconsidered despite being essential for successful antiadhesion therapy.Keywords
This publication has 66 references indexed in Scilit:
- Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformationProceedings of the National Academy of Sciences, 2013
- In Vitro Antimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010Antimicrobial Agents and Chemotherapy, 2012
- Lead Optimization Studies on FimH Antagonists: Discovery of Potent and Orally Bioavailable Ortho-Substituted Biphenyl MannosidesJournal of Medicinal Chemistry, 2012
- Structure-Based Drug Design and Optimization of Mannoside Bacterial FimH AntagonistsJournal of Medicinal Chemistry, 2010
- Structural Basis for Mechanical Force Regulation of the Adhesin FimH via Finger Trap-like β Sheet TwistingCell, 2010
- Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose bindingProceedings of the National Academy of Sciences, 2009
- FimH Forms Catch Bonds That Are Enhanced by Mechanical Force Due to Allosteric RegulationJournal of Biological Chemistry, 2008
- Allostery: Absence of a Change in Shape Does Not Imply that Allostery Is Not at PlayJournal of Molecular Biology, 2008
- Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteriaProceedings of the National Academy of Sciences, 2006
- The affinity of the FimH fimbrial adhesin is receptor‐driven and quasi‐independent of Escherichia coli pathotypesMolecular Microbiology, 2006